These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31437396)

  • 21. Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical development.
    Mohammed AR; Bramwell VW; Kirby DJ; McNeil SE; Perrie Y
    Eur J Pharm Biopharm; 2010 Nov; 76(3):404-12. PubMed ID: 20884349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome-based cationic adjuvant formulations (CAF): past, present, and future.
    Christensen D; Agger EM; Andreasen LV; Kirby D; Andersen P; Perrie Y
    J Liposome Res; 2009; 19(1):2-11. PubMed ID: 19515003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.
    Hamborg M; Rose F; Jorgensen L; Bjorklund K; Pedersen HB; Christensen D; Foged C
    Biochim Biophys Acta; 2014 Aug; 1838(8):2001-10. PubMed ID: 24769435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and manufacturing of lymphatic targeting liposomes using microfluidics.
    Khadke S; Roces CB; Cameron A; Devitt A; Perrie Y
    J Control Release; 2019 Aug; 307():211-220. PubMed ID: 31170464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.
    Ingvarsson PT; Yang M; Mulvad H; Nielsen HM; Rantanen J; Foged C
    Pharm Res; 2013 Nov; 30(11):2772-84. PubMed ID: 23794038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models.
    Ingvarsson PT; Rasmussen IS; Viaene M; Irlik PJ; Nielsen HM; Foged C
    Eur J Pharm Biopharm; 2014 Aug; 87(3):480-8. PubMed ID: 24726978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.
    Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X
    Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel Mycobacterium tuberculosis fusion protein: a multivariate analysis study.
    Kastner E; Hussain MJ; Bramwell VW; Christensen D; Perrie Y
    J Pharm Pharmacol; 2015 Mar; 67(3):450-63. PubMed ID: 25677402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant.
    Perrie Y; Kastner E; Kaur R; Wilkinson A; Ingham AJ
    Hum Vaccin Immunother; 2013 Jun; 9(6):1374-81. PubMed ID: 23584249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production.
    Henriksen-Lacey M; Devitt A; Perrie Y
    J Control Release; 2011 Sep; 154(2):131-7. PubMed ID: 21640145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of Th1-Type Immune Responses to
    Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG
    J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
    Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction.
    Wørzner K; Hvannastein J; Schmidt ST; Foged C; Rosenkrands I; Pedersen GK; Christensen D
    Eur J Pharm Biopharm; 2021 Aug; 165():293-305. PubMed ID: 34044110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations.
    Lou G; Anderluzzi G; Woods S; Roberts CW; Perrie Y
    Eur J Pharm Biopharm; 2019 Oct; 143():51-60. PubMed ID: 31445156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV.
    Mansury D; Ghazvini K; Amel Jamehdar S; Badiee A; Tafaghodi M; Nikpoor AR; Amini Y; Jaafari MR
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):370-377. PubMed ID: 30691310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.
    Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A
    Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics.
    Hamborg M; Jorgensen L; Bojsen AR; Christensen D; Foged C
    Pharm Res; 2013 Jan; 30(1):140-55. PubMed ID: 22956169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocorrelates of CAF family adjuvants.
    Pedersen GK; Andersen P; Christensen D
    Semin Immunol; 2018 Oct; 39():4-13. PubMed ID: 30396811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes.
    Agallou M; Margaroni M; Tsanaktsidou E; Badounas F; Kammona O; Kiparissides C; Karagouni E
    J Control Release; 2023 Apr; 356():386-401. PubMed ID: 36893900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
    Korsholm KS; Hansen J; Karlsen K; Filskov J; Mikkelsen M; Lindenstrøm T; Schmidt ST; Andersen P; Christensen D
    Vaccine; 2014 Jun; 32(31):3927-35. PubMed ID: 24877765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.